MIGS Glaucoma Surgery in London: A Guide to Minimally Invasive Treatment

Author : Mr Minak Bhalla Private Ophthalmologist London | Published On : 30 Sep 2026

Glaucoma is a group of eye conditions that can progressively damage the optic nerve and cause irreversible sight loss. Because glaucoma may develop gradually without obvious symptoms, regular eye examinations and timely treatment are important for protecting vision. For many people, treatment begins with prescription eye drops or laser therapy. When these approaches do not provide sufficient control of intraocular pressure (IOP), surgery may be considered.

One of the developments in modern glaucoma care is Minimally Invasive Glaucoma Surgery (MIGS). MIGS includes a range of surgical procedures designed to lower eye pressure using relatively small incisions and specialised devices or techniques.

For patients researching MIGS glaucoma surgery in London, specialist ophthalmology services provide access to clinicians experienced in glaucoma diagnosis, medical treatment and surgery. However, MIGS is not a single procedure or a universal solution. The most appropriate treatment depends on the type and severity of glaucoma, the target eye pressure and the individual patient's circumstances.

What Is MIGS Glaucoma Surgery?

MIGS stands for Minimally Invasive Glaucoma Surgery. It describes a group of procedures designed to improve the drainage of aqueous humour—the clear fluid produced inside the eye—and consequently reduce IOP.

In a healthy eye, aqueous humour continuously circulates through the front of the eye before draining through the eye's natural outflow pathways. If drainage becomes restricted, pressure inside the eye can increase. Elevated IOP is an important risk factor for optic nerve damage in many forms of glaucoma.

MIGS procedures aim to improve fluid drainage. Depending on the particular technique, a surgeon may bypass resistance in the natural drainage pathway, open or improve existing channels, or create another route through which fluid can leave the eye.

The Royal College of Ophthalmologists' UK MIGS training programme covers a variety of technologies, including iStent, Hydrus, OMNI, iTrack, ELIOS and MiniJect. This demonstrates that MIGS is a broad category rather than one standard operation.

Why Is MIGS Used?

The principal objective of glaucoma treatment is to reduce the risk of further optic nerve damage. Lowering IOP is an important part of treatment for many glaucoma patients.

Prescription eye drops can be effective at reducing IOP, but some patients need several medications or find long-term treatment difficult. Problems can include ocular irritation, difficulty administering drops or the inconvenience of using medication every day.

Laser treatment, including selective laser trabeculoplasty in appropriate patients, is another option. If pressure remains above the desired target despite these approaches, surgery may be discussed.

MIGS can provide an additional surgical option for carefully selected patients. Depending on the procedure, potential objectives include reducing IOP and decreasing reliance on glaucoma medication.

However, patients should understand that MIGS is not intended to reverse optic nerve damage that has already occurred. Its role is to help control glaucoma and reduce the risk of future progression.

Who May Be Suitable for MIGS?

MIGS is generally considered for selected patients, particularly those with certain forms of open-angle glaucoma. Suitability varies according to the specific procedure.

Before recommending MIGS, a glaucoma specialist will usually assess several aspects of the patient's condition, including:

  • Type and stage of glaucoma
  • Current intraocular pressure
  • Target IOP
  • Optic nerve appearance
  • Visual-field results
  • OCT findings
  • Drainage-angle anatomy
  • Previous glaucoma treatments
  • Response to medication or laser treatment
  • Presence of cataracts or other eye conditions

The amount of pressure reduction required is particularly important. A patient with relatively early glaucoma may have different treatment requirements from someone with advanced optic nerve damage.

The National Institute for Health and Care Excellence (NICE) describes glaucoma as a chronic condition in which treatment may include medication and a range of surgical or laser approaches. Surgical treatment needs to be considered in the context of the individual's clinical circumstances.

Different Types of MIGS

There are several MIGS techniques available or used in specialist glaucoma practice. They work in different ways and have different indications.

Trabecular Micro-Bypass

Some MIGS devices are designed to bypass resistance within the trabecular meshwork and improve aqueous humour flow into the natural drainage system.

The iStent is one example of a trabecular micro-bypass device included in specialist MIGS training in the UK.

Hydrus Microstent

The Hydrus Microstent is an intracanalicular device designed to support and improve aqueous humour drainage through Schlemm's canal. It is another technology covered by the Royal College of Ophthalmologists' MIGS training programme.

Canaloplasty and Trabeculotomy

Some MIGS procedures work with the eye's natural drainage structures. Canaloplasty aims to improve the function of the drainage canal, while trabeculotomy addresses resistance at the trabecular meshwork.

The OMNI system combines canaloplasty and trabeculotomy approaches and is among the technologies included in UK MIGS surgical training.

Other MIGS Approaches

The field also includes catheter-based canaloplasty, excimer laser trabeculostomy and procedures involving other parts of the eye's outflow system. Newer technologies continue to be evaluated and incorporated into specialist practice.

Because each procedure has its own mechanism, benefits, limitations and risks, patients should ask their surgeon which specific technique is being recommended.

MIGS and Cataract Surgery

Some MIGS procedures can be performed alongside cataract surgery.

Cataracts cause clouding of the natural lens and can affect visual clarity. Glaucoma is a separate disease affecting the optic nerve. It is possible for the two conditions to occur in the same patient, particularly with increasing age.

If a patient requires cataract surgery and also needs additional glaucoma treatment, combined cataract and MIGS surgery may sometimes be considered.

The decision depends on factors such as glaucoma severity, current IOP, medication requirements, target pressure and the patient's overall eye health. Not everyone having cataract surgery and glaucoma treatment will require MIGS.

A glaucoma specialist can explain whether combining procedures is appropriate and what outcomes might reasonably be expected.

What Happens During MIGS Surgery?

The exact experience depends on the procedure being performed.

MIGS generally uses specialised microscopic instruments through a small surgical opening. The surgeon accesses the relevant drainage structures and performs the selected procedure under appropriate anaesthesia.

Before surgery, patients should receive a detailed explanation of the treatment, including its purpose, potential benefits, possible complications and alternative options.

After the procedure, postoperative medication is commonly prescribed, and follow-up appointments are required. These appointments allow the ophthalmologist to monitor IOP, inflammation and healing.

The term "minimally invasive" should not be interpreted as meaning that the procedure has no risks. MIGS remains eye surgery and requires appropriate patient selection and postoperative care.

Recovery After MIGS

Recovery varies depending on the type of MIGS procedure and whether it is combined with another operation such as cataract surgery.

Because MIGS generally involves relatively small surgical approaches, some procedures may have a comparatively straightforward recovery. Nevertheless, patients should follow their surgeon's instructions carefully.

Temporary restrictions may apply to activities such as strenuous exercise, swimming or heavy lifting. The surgeon will also advise when it is appropriate to return to work and resume driving.

Follow-up is an important part of recovery. The initial postoperative IOP may not represent the final long-term pressure level, so continued monitoring is needed.

Potential Benefits of MIGS

For appropriately selected patients, MIGS may provide several potential benefits.

These include:

  • Reduction in intraocular pressure
  • A minimally invasive surgical approach
  • Potential reduction in the number of glaucoma medications required
  • A further option when medication or laser treatment is insufficient
  • The possibility of combining glaucoma treatment with cataract surgery
  • Potentially straightforward recovery with some procedures

However, outcomes vary between patients and procedures. MIGS does not guarantee that a patient will stop using glaucoma medication, and it does not eliminate the need for long-term glaucoma monitoring.

Limitations and Risks of MIGS

MIGS is not appropriate for every glaucoma patient.

One important consideration is the amount of pressure reduction required. Patients with advanced glaucoma may need very low target pressures. In such situations, conventional glaucoma surgery, such as trabeculectomy or glaucoma drainage device surgery, may be considered.

Potential surgical complications vary according to the particular MIGS technique. They can include inflammation, bleeding, changes in eye pressure, infection or the need for additional treatment.

The Royal College of Ophthalmologists recognises MIGS as part of the surgical options that glaucoma surgeons train in, alongside other procedures used to lower IOP. Its training framework emphasises understanding when surgery is appropriate and selecting procedures according to clinical indications.

Consequently, the least invasive treatment is not automatically the most suitable treatment for every patient.

Why Choose a Specialist for MIGS in London?

London has a large concentration of specialist ophthalmology services, including dedicated glaucoma expertise. Patients considering MIGS can seek assessment from an ophthalmologist with specialist experience in glaucoma diagnosis and surgery.

When choosing a clinic or surgeon, it is useful to consider more than the location. Patients may wish to ask about:

  • The surgeon's specialist glaucoma training
  • Experience with the specific MIGS procedure being proposed
  • Preoperative diagnostic testing
  • Postoperative monitoring
  • Alternative treatment options
  • Emergency or out-of-hours arrangements
  • The likely overall treatment pathway

The Royal College of Ophthalmologists explains that ophthalmologists diagnose, treat and manage eye disease and that ophthalmology combines clinical assessment with surgery.

A specialist consultation should provide an opportunity to understand why a particular procedure is being recommended and whether another approach might be more appropriate.

Questions to Ask Your MIGS Specialist

If you are considering MIGS glaucoma surgery in London, preparing questions before your consultation can be helpful.

You may wish to ask:

  1. What type and stage of glaucoma do I have?
  2. What is my target eye pressure?
  3. Why is MIGS being recommended for me?
  4. Which specific MIGS procedure is being proposed?
  5. How much pressure reduction might be expected?
  6. Will I still need glaucoma eye drops afterwards?
  7. Could laser treatment be an alternative?
  8. Would conventional glaucoma surgery be more appropriate?
  9. Can MIGS be combined with cataract surgery?
  10. What are the potential risks and complications?
  11. How long might recovery take?
  12. What follow-up care will I need?

Understanding these points can help you make an informed decision based on your individual eye health.

The Importance of Long-Term Glaucoma Monitoring

MIGS is a treatment for glaucoma management, not a cure that removes the need for ongoing care.

Even after successful surgery, patients generally require regular examinations. The ophthalmologist may monitor IOP, optic nerve structure and visual-field performance to determine whether glaucoma remains stable.

If IOP rises again or the disease progresses, additional medication, laser treatment or another surgical procedure may be considered.

Long-term follow-up is therefore just as important as the surgery itself.

Conclusion

MIGS glaucoma surgery in London represents an important development in modern glaucoma care. Minimally Invasive Glaucoma Surgery encompasses a range of procedures designed to improve aqueous humour drainage and lower intraocular pressure through relatively small surgical interventions.

For selected patients, MIGS may help control IOP and potentially reduce dependence on glaucoma medication. Some techniques can also be combined with cataract surgery when clinically appropriate.

However, MIGS is not suitable for everyone. The right treatment depends on the type and severity of glaucoma, the required target pressure, eye anatomy, previous treatments and the patient's overall circumstances.

A consultation with a qualified glaucoma specialist can help establish whether MIGS is appropriate and which procedure, if any, is suitable. Patients should consider the potential benefits, limitations, risks and alternatives before proceeding.

The ultimate objective of glaucoma treatment is to protect remaining vision by achieving appropriate long-term disease control. With appropriate diagnosis, personalised treatment and regular monitoring, patients can take important steps towards maintaining their eye health and quality of life.

Disclaimer: This article is intended for general educational purposes and does not constitute medical advice. MIGS is not appropriate for every patient, and individual treatment recommendations should be made by a qualified ophthalmologist or glaucoma specialist following a comprehensive clinical assessment.